Sign in

mina-t.bsky.social

@mina-t.bsky.social
41 followers 60 following 10 posts
PostsRepliesMedia
Reposted by @mina-t.bsky.social
Ontario Drug Policy Research Network @odprn.bsky.social · 26/06/2025
We’re thrilled to share that ODPRN Co-Director @mina-t.bsky.social has been promoted to Associate Professor at @uoftpharmacy.bsky.social! We are incredibly proud to have him on our team and look forward to his continued leadership as he takes on this exciting new role. 🎉 🎉
011
Reposted by @mina-t.bsky.social
Ontario Drug Policy Research Network @odprn.bsky.social · 25/04/2025
Join the ODPRN Virtual Town Hall on Pharmacist Prescribing for Minor Ailments in Ontario! 📅 June 17, 2025 ⏰ 12:00 – 1:30 pm EDT Share your experiences & ideas to improve services and access. Facilitator @mina-t.bsky.social will be there to answer questions. odprn.ca/town-halls/
011
Reposted by @mina-t.bsky.social
Ontario Drug Policy Research Network @odprn.bsky.social · 09/04/2025
ODPRN's Director of Pharmacy Practice and Pharmaceutical Policy, @mina-t.bsky.social, speaks with @globalnews.ca.web.brid.gy about tariffs on prescription drugs in Canada. ca.news.yahoo.com/health-matte...
ca.news.yahoo.com
Health Matters: How do tariffs on prescription drugs work?
U.S. President Donald Trump wants to slap tariffs on Canadian-made drugs. Can he do that and what would it mean for drug supply and cost? We speak with Mina Tadrous from the University of Toronto.
011
Reposted by @mina-t.bsky.social
ICES Ontario @icesontario.bsky.social · 09/04/2025
#ICESOntario scientist Dr. Mina Tadrous @mina-t.bsky.social discusses how tariffs would affect Canadian-made drugs on @globalnews.ca.web.brid.gy
021
mina-t.bsky.social @mina-t.bsky.social · 04/04/2025
We’re analyzing (early teaser) where the U.S. really gets its final drug dosages from—and early data is eye-opening. This is why drug supply chains must be protected from strain—including #tariffs. Global thinking is essential here.
000
Reposted by @mina-t.bsky.social
André Picard @picardonhealth @picardonhealth.bsky.social · 31/03/2025
Trump’s proposed tariffs likely to cause shortages of Canadian-made drugs in U.S., study says. 25% tariffs would lead to an increased cost of US$750-million for American buyers, research says, by @hannay.bsky.social www.theglobeandmail.com/business/eco... via @theglobeandmail.com
theglobeandmail.com
Trump’s proposed tariffs likely to cause shortages of Canadian-made drugs in U.S., study says
25% tariffs would lead to an increased cost of US$750-million for American buyers, research says
13919
mina-t.bsky.social @mina-t.bsky.social · 01/04/2025
A little break from doom scrolling courtesy of PhD Student Martin Ho and how he sees my work at the pharmacy. @uoftpharmacy.bsky.social
040
Reposted by @mina-t.bsky.social
The Globe and Mail @theglobeandmail.com · 31/03/2025
theglobeandmail.com
Trump’s proposed tariffs likely to cause shortages of Canadian-made drugs in U.S., study says
25% tariffs would lead to an increased cost of US$750-million for American buyers, research says
53118
Reposted by @mina-t.bsky.social
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 31/03/2025
🆕! Talk of tariffs is leaving many confused about how they'll affect drug prices & supply in the US. In JAMA, experts @mina-t.bsky.social & Dr. Katie Suda & team describe how tariffs on Canadian 💊 will impact US patients & payers. jamanetwork.com/journals/jam...
041
Reposted by @mina-t.bsky.social
JAMA @jama.com · 31/03/2025
Tariffs on pharmaceutical drugs manufactured in Canada could raise US costs by $750 million and strain supply chains, with brand-name drugs likely absorbing short-term increases. ja.ma/4l3QSbv
01510
Reposted by @mina-t.bsky.social
Ontario Drug Policy Research Network @odprn.bsky.social · 04/03/2025
"Americans will feel the pain in their medicine chest when their antibiotics, vaccines, and prescriptions suddenly jump in cost by 25 percent" - @mina-t.bsky.social @edmontonjournal.bsky.social edmontonjournal.com/news/world/t...
edmontonjournal.com
How Donald Trump’s tariff on pharmaceuticals could cause headaches for American patients and Canadian companies
Americans will feel the pain in their medicine chest when their antibiotics, vaccines, and prescriptions suddenly jump in cost by 25%.
011
Reposted by @mina-t.bsky.social
Ontario Drug Policy Research Network @odprn.bsky.social · 18/02/2025
In an interview with @cbcnews-rss.bsky.social, @mina-t.bsky.social explains the impact of potential tariffs on medical equipment and drugs. www.cbc.ca/player/play/...
cbc.ca
Mina Tadrous explains the impact of potential tariffs on medical equipment and drugs
Get the latest on CBCNews.ca, the CBC News App, and CBC News Network for breaking news and analysis.
011
Reposted by @mina-t.bsky.social
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 05/02/2025
This study examined @WHO recommended National Action Plan post-implementation changes in antibiotic utilization among 38 countries. Authors include @mina-t.bsky.social & CP3's Tate Miner, @CallawayKim4, & @Sudamonas Presented @IDWeekmtg & pub in @OFIDJournal academic.oup.com/ofid/article...
011
Reposted by @mina-t.bsky.social
Ontario Drug Policy Research Network @odprn.bsky.social · 03/02/2025
Join the ODPRN Virtual Town Hall on Pharmacist Prescribing for Minor Ailments in Ontario! 📅 March 4, 2025 ⏰ 1:00 – 2:30 pm EDT Share your experiences & ideas to improve services and access. Facilitator @mina-t.bsky.social will be there to answer questions. odprn.ca/town-halls/
011
Reposted by @mina-t.bsky.social
JAMA @jama.com · 02/02/2025
This study identifies inconsistent evaluation practices of large language models (LLMs) in health care, finding a lack of standardized frameworks and limited use of real patient data. ja.ma/40WLHSt #MedSky
12110
Reposted by @mina-t.bsky.social
ICES Ontario @icesontario.bsky.social · 27/01/2025
Statistical methods are the backbone of health research. #ICESOntario senior core scientist Dr. Peter Austin shares how his work is helping shape health outcomes in Ontario and offers some key advice for future statisticians. Read more: www.ices.on.ca/story...
021
Reposted by @mina-t.bsky.social
Ontario Drug Policy Research Network @odprn.bsky.social · 27/01/2025
Government of Canada signs bilateral agreement with Ontario for Drugs for Rare Diseases. “Ontario is making it easier and faster for people of all ages, living with rare diseases to connect to the treatment they need" - Sylvia Jones www.canada.ca/en/health-ca...
canada.ca
Government of Canada signs bilateral agreement with Ontario for Drugs for Rare Diseases
Today, the Honourable Mark Holland, Canada’s Minister of Health, and the Honourable Sylvia Jones, Ontario’s Minister of Health, announced a bilateral agreement investing over $535 million to improve a...
011
mina-t.bsky.social @mina-t.bsky.social · 07/01/2025
Merry Orthodox Christmas to everyone celebrating today!
000
mina-t.bsky.social @mina-t.bsky.social · 07/01/2025
Excited to see Health Canada's proposed Critical Drug List (CVDL), a step in addressing drug shortages. Our tool, balancing clinical & supply chain risks, was cited as a vital component in shaping this. Learn more: www.canada.ca/en/health-ca... #DrugShortages
000
mina-t.bsky.social @mina-t.bsky.social · 30/12/2024
Health Canada published their proposed regs to address shortages. This includes mandatory safety stocks and shortage plans. This includes the list of drugs affected. 🔗 canadagazette.gc.ca/rp-pr/p1/202... #supplychain #drugshortages #pharmaceuticals #healthpolicy
canadagazette.gc.ca
Canada Gazette, Part 1, Volume 158, Number 52: Regulations Amending Certain Regulations Made Under the Food and Drugs Act (Shortages and Discontinuation of Sale of Drugs and Medical Devices)
December 28, 2024, Part 1, Volume 158, Number 52, Canada Gazette
000
mina-t.bsky.social @mina-t.bsky.social · 23/12/2024
Happy Festivus!! We begin with the traditional airing of grievances. I'll start (same again)-> journals that make you jump through hoops to submit with their format/style/extra parts then quickly desk-reject your paper! #HappyFestivus #phdchat #healthresearch
media.tenor.com
a group of men are sitting at a table in a diner
ALT: a group of men are sitting at a table in a diner
000
Reposted by @mina-t.bsky.social
Ontario Drug Policy Research Network @odprn.bsky.social · 20/12/2024
The latest edition of ODPRN's Quarterly Newsletter is now available on LinkedIn! Here’s what ODPRN has been up to this past Fall and what’s coming up this Winter! www.linkedin.com/posts/ontari...
linkedin.com
Ontario Drug Policy Research Network on LinkedIn: ODPRN Quarterly Newsletter | December 2024
The latest edition of ODPRN's Quarterly Newsletter is now available! Here’s what ODPRN has been up to this past Fall and what’s coming up this Winter!
011
mina-t.bsky.social @mina-t.bsky.social · 19/12/2024
Watch our updated top 15 outpatient drug purchases in 🇨🇦 From our updated forecast paper! canjhealthtechnol.ca/index.php/cj...
010
Reposted by @mina-t.bsky.social
Ontario Drug Policy Research Network @odprn.bsky.social · 19/12/2024
A new study finds that total estimated drug purchases in #Canada for 2023 were ~13.7% higher than in 2022, reflecting accelerated growth likely driven by increased use of new diabetes and obesity treatments. Learn more at: odprn.ca/research/pub... @mina-t.bsky.social
odprn.ca
Canadian Trends in Estimated Drug Purchases and Projections: 2024 and 2025 - ODPRN
Background Data on trends in the pharmaceutical market remain limited, while budget planning is an annual process that requires forecasting potential growth.Objective This study provides an annual upd...
011
mina-t.bsky.social @mina-t.bsky.social · 18/12/2024
🚨 Join Our Team! 🚨 We’re hiring a Research Analyst at UofT's Leslie Dan Faculty of Pharmacy! Work on impactful projects in pharmacoepi & health services research with ICES data. 📍 Toronto, ON 💻 Apply: jobs.utoronto.ca/job/Toronto-Re… Please RT! #Hiring #Pharmacoepi #TorontoJobs
jobs.utoronto.ca
Careers at U of T
View All U of T Faculty Positions, View All U of T Opportunities for External Positions, View All U of T Current Non-Appointed Opportunities, View All U of T Opportunities in Affiliated Hospitals
000
Reposted by @mina-t.bsky.social
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 12/12/2024
Though the US spends more than Canada on 💊purchases, that doesn't translate to better access. Read more @amcporg www.jmcp.org/doi/10.18553... @mina-t.bsky.social @pittgim.bsky.social @pittdeptofmed.bsky.social
023
mina-t.bsky.social @mina-t.bsky.social · 11/12/2024
National Treasure.
000
Reposted by @mina-t.bsky.social
Scott Gavura @pharmacistscott.sciencebasedmedicine.org · 06/12/2024
Americans pay more, do they get more? Per capita spending on drugs in the United States is 2x that of Canada. @mina-t.bsky.social and colleagues look at availability across both countries, and observe similar access to important drugs in both countries. www.jmcp.org/doi/10.18553...
jmcp.org
Fear of missing out: Drug availability in the United States vs Canada | Journal of Managed Care & Specialty Pharmacy
BACKGROUND: Per capita spending on drugs in the United States is double that of Canada. One commonly debated point when comparing the 2 countries is whether this additional spending allows residents o...
032
mina-t.bsky.social @mina-t.bsky.social · 05/12/2024
🚨 New paper alert! Does paying more for drugs in the US mean you’re getting more valuable drugs? The US gets more drugs and gets them sooner, but is the value there? @pittcp3.bsky.social 👉 Read it here: www.jmcp.org/doi/10.18553... #healthpolicy #DrugPricing
jmcp.org
Fear of missing out: Drug availability in the United States vs Canada | Journal of Managed Care & Specialty Pharmacy
BACKGROUND: Per capita spending on drugs in the United States is double that of Canada. One commonly debated point when comparing the 2 countries is whether this additional spending allows residents o...
073
Reposted by @mina-t.bsky.social
JAMA @jama.com · 02/12/2024
Reductions in prices associated with the Medicare Drug Price Negotiation Program differed widely across the 10 drugs. The negotiated prices of all products but 1 remained above list prices in peer countries. ja.ma/3B9rsXF
Figure: Comparison of treatment costs based on prices negotiated by Medicare, initial net prices, and ceiling prices.
3216
Reposted by @mina-t.bsky.social
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 31/10/2024
🆕 in JAMA: study comparing drug shortages in the US & Canada, by team including CP3's @CallawayKim4 @walidgellad & @Sudamonas. They found drug-related supply chain issue reports were 40% less likely to result in meaningful drug shortages in Canada compared with US. jamanetwork.com/journals/jam...
031